Randhawa Simrat bought DNTH
March 12, 2026 · Form 4 insider transaction
Randhawa Simrat bought 8,332 shares of Dianthus Therapeutics, Inc. at $21.77 per share, a transaction worth $181.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,332
Price
$21.77
Total value
$181.4K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after21,330
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.